Hsp90;
cancer;
structure-based drug design;
pyrazole;
X-ray crystallography;
D O I:
10.1016/j.bmcl.2005.08.091
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Information from X-ray crystal structures of Hsp90 inhibitors bound to the human Hsp90 molecular chaperone was used to assist in the design of 3-(5-chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as novel inhibitors of Hsp90. Accessing an extra interaction with the protein via Phe138 gave a significant increase in binding potency compared to similar analogues that do not make this interaction. (c) 2005 Elsevier Ltd. All rights reserved.